NCT03530475

Brief Summary

This study will be conducted on (100) pregnant women diagnosed as placenta previa by ultrasonography and are candidates for either emergency or elective repeated cesarean section or hysterectomy (if the diagnosis of placenta accreta is confirmed). All of those patients are presenting during the period of may 2018 to july 2018 to Kasr-Al Ainy Obstetrics outpatient clinic or casualty department during their 3rd trimester. All of them will be assorted according to certain inclusion and exclusion criterions as follow:

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 21, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

May 22, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 22, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 22, 2018

Completed
Last Updated

May 25, 2018

Status Verified

May 1, 2018

Enrollment Period

3 months

First QC Date

May 7, 2018

Last Update Submit

May 23, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • accuracy of ultrasound and doppler in detecting placenta accreta

    accuracy of uterine artery doppler in diagnosing placenta accreta diagnosed intraoperative or by histopathological examination done after cesarian hysterectomy

    3 moths

Secondary Outcomes (1)

  • accuracy of ultrasound in detecting placenta accreta diagnosed intraoperative or by histopathological examination done after cesarian hysterectomy

    3 months

Study Arms (2)

placenta previa

ACTIVE COMPARATOR

cases diagnosed as placenta previa diagnosed by ultrasound and doppler

Diagnostic Test: ultrasound and doppler

placenta accreta

ACTIVE COMPARATOR

placenta previa diagnosed as placenta accreta by ultrasound and doppler

Diagnostic Test: ultrasound and doppler

Interventions

ultrasound and dopplerDIAGNOSTIC_TEST

• Ultrasound examination (2D gray scale and color doppler ) 1\. Confirming the presence of placenta previa 2,To assess the possibility of concomitant placenta accreta (Sonographic findings that have been associated with placenta accreta (1) Loss of normal hypoechoic retroplacental zone (2) Multiple vascular lacunae (irregular vascular spaces) within placenta, (3) Blood vessels or placental tissue bridging uterine-placental margin, myometrial-bladder interface, or crossing uterine serosa1 (4) Retroplacental myometrial thickness of 1 mm (5) Bladder wall interruption (6) Presence of placental bulge (7) Utero-vesical hypervascularity (8) presence of lacunae feeder vessels. 3\. Assessment of uterine artery Doppler in different cases of placenta previa. . Documentation of the operative findings during cesarean section and/or cesarean hysterectomy procedures. Histopathological examination of the hysterectomy specimens to assess the degree of myometrial invasion.

placenta accretaplacenta previa

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Gestational age more than 28 weeks
  • Single living fetus.
  • One or more cesarean section or hysterotomy.
  • Placenta previa (all grades) with high possibility of morbidly adherent placenta accreta (all types).

You may not qualify if:

  • Maternal chronic medical disorder (diabetes mellitus or hypertension).
  • Pregnancy induced disorders (pre-eclampsia or gestational diabetes).
  • Associated fetal anomalies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Placenta Accreta

Interventions

Ultrasonography, Doppler

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Intervention Hierarchy (Ancestors)

UltrasonographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Hala Nabil, M.D

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

May 7, 2018

First Posted

May 21, 2018

Study Start

May 22, 2018

Primary Completion

August 22, 2018

Study Completion

August 22, 2018

Last Updated

May 25, 2018

Record last verified: 2018-05